The eye in sleep apnea syndrome

Sleep Med. 2006 Mar;7(2):107-15. doi: 10.1016/j.sleep.2005.08.010. Epub 2006 Feb 3.

Abstract

Sleep apnea syndrome (SAS) is a disease characterized by recurrent complete or partial upper airway obstructions during sleep. The majority of patients with SAS demonstrate this obstruction either at the nasopharynx or the oropharynx. Risk factors for SAS include obesity, male gender, upper airway abnormalities, alcohol use, snoring, and neck girth of more than 17 in. in men or 16 in. in women. Reported ophthalmic findings in patients with SAS include floppy eyelid syndrome (FES), glaucoma, and non-arteritic anterior ischemic optic neuropathy (NAION).

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Continuous Positive Airway Pressure / methods
  • Elastin / metabolism
  • Erythromycin / therapeutic use
  • Eye / physiopathology*
  • Eyelid Diseases / drug therapy
  • Eyelid Diseases / epidemiology*
  • Eyelid Diseases / physiopathology*
  • Glaucoma / diagnosis
  • Glaucoma / epidemiology*
  • Glaucoma / physiopathology
  • Humans
  • Marfan Syndrome / diagnosis
  • Marfan Syndrome / epidemiology*
  • Marfan Syndrome / physiopathology
  • Optic Nerve / physiopathology
  • Optic Neuropathy, Ischemic / diagnosis
  • Optic Neuropathy, Ischemic / epidemiology*
  • Optic Neuropathy, Ischemic / physiopathology
  • Sleep Apnea, Obstructive / epidemiology*
  • Sleep Apnea, Obstructive / physiopathology*
  • Sleep Apnea, Obstructive / therapy

Substances

  • Anti-Bacterial Agents
  • Erythromycin
  • Elastin